Clinical Trial Update: Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the anti-inflammatory potential of alpha-lipoic acid in multiple sclerosis; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Portland VA Medical Center | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED | Results posted: 2017-01-26